Ident. | Authors (with country if any) | Title |
---|
002833 (2013) |
Kristian Thorlund [Canada] ; Eric Druyts [Canada] ; J Antonio Avi A-Zubieta [Canada] ; Ping Wu [Canada] ; Edward J. Mills [Canada] | Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings |
002838 (2013) |
Samantha Louise Smith [Royaume-Uni] ; Darren Plant [Royaume-Uni] ; Stephen Eyre [Royaume-Uni] ; Anne Barton [Royaume-Uni] | The potential use of expression profiling: implications for predicting treatment response in rheumatoid arthritis |
002839 (2013) |
Maxime Dougados [France] ; Valérie Devauchelle-Pensec [France] ; Jean François Ferlet [France] ; Sandrine Jousse-Joulin [France] ; Maria-Antonietta D'Agostino [France] ; Marina Backhaus [Allemagne] ; Jacques Bentin [Belgique] ; Gérard Chalès [France] ; Isabelle Chary-Valckenaere [France] ; Philip Conaghan [Royaume-Uni] ; Richard J. Wakefield [Royaume-Uni] ; Frédéric Etcheparre [France] ; Philippe Gaudin [France] ; Walter Grassi [Italie] ; Désirée Van Der Heijde [Pays-Bas] ; Xavier Mariette [France] ; Esperanza Naredo [Espagne] ; Marcin Szkudlarek [Danemark] | The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound |
002840 (2013) |
Mark C. Genovese [États-Unis] ; Roy M. Fleischmann [États-Unis] ; Maria Greenwald [États-Unis] ; Julie Satterwhite [États-Unis] ; Melissa Veenhuizen [États-Unis] ; Li Xie [États-Unis] ; Pierre-Yves Berclaz [États-Unis] ; Stephen Myers [États-Unis] ; Olivier Benichou [États-Unis] | Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors |
002842 (2013) |
Daniel Aletaha [Autriche] ; Farideh Alasti [Autriche] ; Josef S. Smolen [Autriche] | Rituximab dissociates the tight link between disease activity and joint damage in rheumatoid arthritis patients |
002854 (2013) |
Carrie L. Wagner [États-Unis] ; Sudha Visvanathan [États-Unis] ; Michael Elashoff [États-Unis] ; Iain B. Mcinnes [Royaume-Uni] ; Philip J. Mease [États-Unis] ; Gerald G. Krueger [États-Unis] ; Frederick T. Murphy [États-Unis] ; Kim Papp [Canada] ; Juan J. Gomez-Reino [Espagne] ; Michael Mack [États-Unis] ; Anna Beutler [Canada] ; Dafna Gladman [Canada] ; Arthur Kavanaugh [États-Unis] | Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab |
002855 (2013) |
C. Malattia [Italie] ; A. Consolaro [Italie] ; S. Pederzoli [Italie] ; A. Madeo [Italie] ; A. Pistorio [Italie] ; M. Mazzoni [Italie] ; C. Mattiuz [Italie] ; Gm Magnano [Italie] ; S. Viola [Italie] ; A. Buoncompagni [Italie] ; E. Palmisani [Italie] ; R. Hasija [Italie] ; N. Ruperto [Italie] ; A. Ravelli [Italie] ; A. Martini [Italie] | MRI versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in juvenile idiopathic arthritis |
002859 (2013) |
Stephanie Finzel [Allemagne] ; Juergen Rech [Allemagne] ; Sarah Schmidt [Allemagne] ; Klaus Engelke [Allemagne] ; Matthias Englbrecht [Allemagne] ; Georg Schett [Allemagne] | Interleukin-6 receptor blockade induces limited repair of bone erosions in rheumatoid arthritis: a micro CT study |
002861 (2013) |
Yvonne C. Lee [États-Unis] ; Bing Lu [États-Unis] ; Gilles Boire [Canada] ; Boulos Paul Haraoui [Canada] ; Carol A. Hitchon [Canada] ; Janet E. Pope [Canada] ; J Carter Thorne [Canada] ; Edward Clark Keystone [Canada] ; Daniel H. Solomon [États-Unis] ; Vivian P. Bykerk [États-Unis, Canada] | Incidence and predictors of secondary fibromyalgia in an early arthritis cohort |
002864 (2013) |
Philip G. Conaghan [Royaume-Uni] ; Patrick Durez [Belgique] ; Rieke E. Alten [Allemagne] ; Gerd-Rüdiger Burmester [Allemagne] ; Paul P. Tak [Pays-Bas, Royaume-Uni] ; Lars Klareskog [Suède] ; Anca Irinel Catrina [Suède] ; Julie Dicarlo [États-Unis] ; Corine Gaillez [France] ; Manuela Le Bars [France] ; Xianhuang Zhou [États-Unis] ; Charles Peterfy [États-Unis] | Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial |
002865 (2013) |
Yuko Shirota [États-Unis] ; Cheryl Yarboro [États-Unis] ; Randy Fischer [États-Unis] ; Tuyet-Hang Pham [États-Unis] ; Peter Lipsky [États-Unis] ; Gabor G. Illei [États-Unis] | Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus |
002866 (2013) |
Markku Hakala [Finlande] ; Kai Immonen [Finlande] ; Markku Korpela [Finlande] ; Mikko Vasala [Finlande] ; Markku J. Kauppi [Finlande] | Good medium-term efficacy of tocilizumab in DMARD and anti-TNF-α therapy resistant reactive amyloidosis |
002867 (2013) |
Tsutomu Takeuchi [Japon] ; Masayoshi Harigai [Japon] ; Yoshiya Tanaka [Japon] ; Hisashi Yamanaka [Japon] ; Naoki Ishiguro [Japon] ; Kazuhiko Yamamoto [Japon] ; Nobuyuki Miyasaka [Japon] ; Takao Koike [Japon] ; Minoru Kanazawa [Japon] ; Takuya Oba [Japon] ; Toru Yoshinari [Japon] ; Daniel Baker [États-Unis] | Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks |
002869 (2013) |
Marieke H. Otten [Pays-Bas] ; Janneke Anink [Pays-Bas] ; Sandra Spronk [Pays-Bas] ; Lisette W A. Van Suijlekom-Smit [Pays-Bas] | Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons |
002871 (2013) |
John D. Isaacs [Royaume-Uni] ; Stanley B. Cohen [États-Unis] ; Paul Emery [Royaume-Uni] ; Paul P. Tak [Pays-Bas, Royaume-Uni] ; Jianmei Wang [Royaume-Uni] ; Guiyuan Lei [Royaume-Uni] ; Sarah Williams [Royaume-Uni] ; Preeti Lal [États-Unis] ; Simon J. Read [Royaume-Uni] | Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis |
002874 (2013) |
Josef S. Smolen [Autriche] ; Monika M. Schoels [Autriche] ; Norihiro Nishimoto [Japon] ; Ferdinand C. Breedveld [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maxime Dougados [France] ; Paul Emery [Royaume-Uni] ; Gianfranco Ferraccioli [Italie] ; Cem Gabay [Suisse] ; Allan Gibofsky [États-Unis] ; Juan Jesus Gomez-Reino [Espagne] ; Graeme Jones [Australie] ; Tore K. Kvien [Norvège] ; Miho Murakami [Japon] ; Neil Betteridge [Royaume-Uni] ; Clifton O. Bingham [États-Unis] ; Vivian Bykerk [Suisse] ; Ernest H. Choy [Royaume-Uni] ; Bernard Combe [France] ; Maurizio Cutolo [Italie] ; Winfried Graninger [Autriche] ; Angel Lanas [Espagne] ; Emilio Martin-Mola [Espagne] ; Carlomaurizio Montecucco [Italie] ; Mikkel Ostergaard [Danemark] ; Karel Pavelka [République tchèque] ; Andrea Rubbert-Roth [Allemagne] ; Naveed Sattar [Royaume-Uni] ; Marieke Scholte-Voshaar [Suisse] ; Yoshiya Tanaka [Japon] ; Michael Trauner [Autriche] ; Gabriele Valentini [Italie] ; Kevin L. Winthrop [États-Unis] ; Maarten De Wit [Pays-Bas] ; Désirée Van Der Heijde [Pays-Bas] | Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions |
002875 (2013) |
Bente Glintborg [Danemark] ; Mikkel Stergaard [Danemark] ; Niels Steen Krogh [Danemark] ; Ulrik Tarp [Danemark] ; Natalia Manilo [Danemark] ; Anne Gitte Rasmussen Loft [Danemark] ; Annette Hansen [Danemark] ; Annette Schlemmer [Danemark] ; Victoria Fana [Danemark] ; Hanne M. Lindegaard [Danemark] ; Henrik Nordin [Danemark] ; Claus Rasmussen [Danemark] ; Leif Ejstrup [Danemark] ; Dorte Vendelbo Jensen [Danemark] ; Peter Mosborg Petersen [Danemark] ; Merete Lund Hetland [Danemark] | Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry |
002876 (2013) |
Paul P. Tak [Royaume-Uni] ; Andra Balanescu [Roumanie] ; Vira Tseluyko [Ukraine] ; Silvia Bojin [Roumanie] ; Edit Drescher [Hongrie] ; Dan Dairaghi [États-Unis] ; Shichang Miao [États-Unis] ; Vittorio Marchesin [États-Unis] ; Juan Jaen [États-Unis] ; Thomas J. Schall [États-Unis] ; Pirow Bekker [États-Unis] | Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial |
002881 (2013) |
Maxime Dougados [France] ; Karsten Kissel [Suisse] ; Tom Sheeran [Royaume-Uni] ; Paul P. Tak [Pays-Bas] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martín Mola [Espagne] ; Georg Schett [Allemagne] ; Howard Amital [Israël] ; Federico Navarro-Sarabia [Espagne] ; Antony Hou [États-Unis] ; Corrado Bernasconi [Suisse] ; Twj Huizinga [Pays-Bas] | Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY) |
002909 (2013) |
T. Harrison ; L. Martin ; C. Barnabe ; K. Fyie [Canada] | THU0599 From Bad to Worse? The Impact of Switching Biologic Agents Multiple Times on Work Productivity and Health-Related Quality of Life for Patients with RA. |
002910 (2013) |
Y. Van Eijk-Hustings [Pays-Bas] ; B. Buss [Allemagne] ; F. Fayet [France] ; A. Moretti [Italie] ; M. Ndosi [Royaume-Uni] ; S. Ryan [Royaume-Uni] ; C. Savel [France] ; M. Scholte-Voshaar [Pays-Bas] ; J. De La Torre-Aboki [Espagne] ; A. Van Tubergen [Pays-Bas] | THU0598 Dissemination and Evaluation of the Eular Recommendations for the Role of the Nurse in the Management of Chronic Inflammatory Arthritis |